A share price of Zai Lab Limited ADR [ZLAB] is currently trading at $31.52, up 6.70%. An important factor to consider is whether the stock is rising or falling in short-term value. The ZLAB shares have gain 9.43% over the last week, with a monthly amount drifted -17.49%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Zai Lab Limited ADR [NASDAQ: ZLAB] stock has seen the most recent analyst activity on March 07, 2025, when Scotiabank initiated its Sector Outperform rating and assigned the stock a price target of $55. Previously, BofA Securities downgraded its rating to Neutral on March 03, 2025, and elevated its price target to $36.10. On December 14, 2023, Morgan Stanley initiated with a Overweight rating and assigned a price target of $47.50 on the stock. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $70 on August 10, 2023. Macquarie initiated its recommendation with a Outperform and recommended $64 as its price target on January 21, 2022. In a note dated April 28, 2020, Goldman initiated an Buy rating.
Zai Lab Limited ADR experienced fluctuations in its stock price throughout the past year between $13.48 and $39.77. Currently, Wall Street analysts expect the stock to reach $55 within the next 12 months. Zai Lab Limited ADR [NASDAQ: ZLAB] shares were valued at $31.52 at the most recent close of the market. An investor can expect a potential return of 74.49% based on the average ZLAB price forecast.
Analyzing the ZLAB fundamentals
Trailing Twelve Months sales for Zai Lab Limited ADR [NASDAQ:ZLAB] were 398.99M which represents 65.68% growth. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at -0.71%, Pretax Profit Margin comes in at -0.64%, and Net Profit Margin reading is -0.64%. To continue investigating profitability, this company’s Return on Assets is posted at -0.22, Equity is -0.35 and Total Capital is -0.32. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 30.46 points at the first support level, and at 29.40 for the second support level. However, for the 1st resistance point, the stock is sitting at 33.02, and for the 2nd resistance point, it is at 34.51.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Zai Lab Limited ADR [NASDAQ:ZLAB] is 3.51. On the other hand, the Quick Ratio is 3.38, and the Cash Ratio is 1.5. Considering the valuation of this stock, the price to sales ratio is 8.66, the price to book ratio is 4.04.
Transactions by insiders
Recent insider trading involved Smiley Joshua L, that happened on Apr 04 ’25 when 3354.0 shares were sold. Chief Legal Officer, Edmondson Frazor Titus III completed a deal on Apr 04 ’25 to sell 1874.0 shares. Meanwhile, Chairperson & CEO Du Ying sold 2945.0 shares on Apr 04 ’25.
